Used in neuroscience research to quantify proNGF levels in biological samples such as brain tissue, cerebrospinal fluid, and cell cultures. Helps investigate neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's by assessing proNGF involvement in neuronal death and inflammation. Supports studies on nerve injury, neuroplasticity, and neuroregeneration. Enables researchers to evaluate therapeutic interventions targeting neurotrophin signaling pathways. Suitable for preclinical studies and biomarker discovery in neurological and psychiatric disorders.